Literature DB >> 21671782

The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study.

Charalambos Pontikis1, Maria P Yavropoulou, Konstantinos A Toulis, Kalliopi Kotsa, Kyriakos Kazakos, Aleka Papazisi, Anna Gotzamani-Psarakou, John G Yovos.   

Abstract

BACKGROUND: Insulin resistance is considered to play an important role in the pathogenesis of polycystic ovary syndrome (PCOS) and in the progression to type 2 diabetes. Recent reports concentrate on a possible relationship between incretin secretion and beta-cell function in PCOS. The aim of the present study is to investigate the incretin effect in obese and lean women with PCOS.
METHODS: Twenty women with PCOS and ten age-matched healthy women were recruited in the study. The oral glucose tolerance test (OGTT) and isoglycemic test were carried out on each participant after an overnight fast at 2-weeks interval. Plasma levels of insulin, glucose, C-peptide, glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) were assayed.
RESULTS: Obese women with PCOS demonstrated lower GIP concentrations (area under the curve [AUC]) in response to OGTT compared to the control group. The incretin effect was found significantly augmented in the obese women with PCOS compared to controls. This finding remained robust in the subgroup analysis including only body mass index (BMI)-matched healthy women.
CONCLUSIONS: Increased insulinotropic effect could counteract the blunted GIP response to OGTT in obese women with PCOS. It is suggested that the pathology of PCOS may also include impaired activity of the enteroinsular axis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671782     DOI: 10.1089/jwh.2010.2272

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  9 in total

Review 1.  Gastrointestinal hormones and polycystic ovary syndrome.

Authors:  Jing Ma; Tzu Chun Lin; Wei Liu
Journal:  Endocrine       Date:  2014-05-04       Impact factor: 3.633

Review 2.  Updates on molecular and environmental determinants of luteal progesterone production.

Authors:  Natalie A DeWitt; Shannon Whirledge; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-06-28       Impact factor: 4.102

Review 3.  Neuroanatomical Framework of the Metabolic Control of Reproduction.

Authors:  Jennifer W Hill; Carol F Elias
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

4.  Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.

Authors:  Namyi Gu; Min Kyu Park; Tae-Eun Kim; Mi Young Bahng; Kyoung Soo Lim; Sang-Heon Cho; Seo Hyun Yoon; Joo-Youn Cho; In-Jin Jang; Kyung-Sang Yu
Journal:  Drug Des Devel Ther       Date:  2014-10-06       Impact factor: 4.162

5.  An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity.

Authors:  Simona Ferjan; Mojca Jensterle; Tjasa Oblak; Irena Prodan Zitnik; Janja Marc; Katja Goricar; Vita Dolzan; Andrej Janez
Journal:  J Int Med Res       Date:  2019-08-23       Impact factor: 1.671

Review 6.  Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives.

Authors:  Mojca Jensterle; Rok Herman; Andrej Janež
Journal:  Biomedicines       Date:  2022-08-16

7.  Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome.

Authors:  Dorte Glintborg; Hanne Mumm; Jens Juul Holst; Marianne Andersen
Journal:  Endocr Connect       Date:  2017-04-21       Impact factor: 3.335

8.  Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.

Authors:  Tao Tao; Peihong Wu; Yuying Wang; Wei Liu
Journal:  BMC Endocr Disord       Date:  2018-02-27       Impact factor: 2.763

9.  The Associations Between Serum Concentrations of Irisin and Glucose-dependent Insulinotropic Polypeptide with Body Mass Index Among Women with and Without Polycystic Ovary Syndrome.

Authors:  Samira Behboudi-Gandevani; Mehdi Hedayati; Mohammad Ali Mansournia; Maryam Nazemipour; Maryam Rahmati; Fahimeh Ramezani Tehrani
Journal:  Int J Endocrinol Metab       Date:  2021-05-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.